Company Profile
Sanofi Stock Price, News & Analysis
- Ticker:
- SNY
- Exchange:
- NASDAQ
- Sector:
- Generics, Antibody Drugs, CNS, Gene Therapy, Novel Therapies, Biopharma, Vaccines
- Location:
- France and listed in the U
Stock performance
42.89 USD (+0.26%)
Close
Last updated: August 6, 2026
102B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, SNY closed up 0.26% at $42.89. No new same-company headline was identified in the current news window.
Company overview
Business overview
Sanofi is a global healthcare company with meaningful exposure to immunology, vaccines, rare disease, and consumer health. The company has been building a more focused innovation story while maintaining a broad global base.
Geographic Base and Sector Classification
Headquartered in France and listed in the U.S. as an ADR, Sanofi operates globally across Europe, the U.S., and other major markets. It is one of the largest international biopharma names.
Business Model Characteristics
Sanofi combines product revenue with pipeline investment and portfolio restructuring. Investors focus on immunology growth, vaccine performance, and the company’s ability to keep improving its innovation mix.
Position Within the Biotechnology Landscape
Sanofi sits in the upper tier of global biopharma, where scale and pipeline quality matter more than single-stock binary events. It still reacts to major clinical and regulatory updates, especially in immunology and rare disease.
Future catalysts
Sanofi should be watched for amlitelimab, tolebrutinib, and the broader immunology pipeline, where any positive progression would reinforce the company’s growth profile. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Sanofi (SNY)?
Sanofi (SNY) most recently closed at 42.89 USD, a +0.26% move versus the previous session.
What is the market cap of Sanofi (SNY)?
Sanofi currently has a market capitalization of 102B USD on BioPharmSignal.
What does Sanofi do?
Sanofi is a global healthcare company with meaningful exposure to immunology, vaccines, rare disease, and consumer health. The company has been building a more focused innovation story while maintaining a broad global base.
On which exchange is SNY stock listed?
Sanofi (SNY) is associated with NASDAQ, France and listed in the U, Generics, Antibody Drugs, CNS, Gene Therapy, Novel Therapies, Biopharma, Vaccines.
What is amlitelimab?
Sanofi should be watched for amlitelimab, tolebrutinib, and the broader immunology pipeline, where any positive progression would reinforce the company’s growth profile.
Which conditions is Sanofi targeting with amlitelimab?
Sanofi is associated with immunology, rare disease based on its company overview and current catalyst commentary.
How does Sanofi describe recent progress with amlitelimab?
Sanofi should be watched for amlitelimab, tolebrutinib, and the broader immunology pipeline, where any positive progression would reinforce the company’s growth profile.
What is tolebrutinib?
Sanofi should be watched for amlitelimab, tolebrutinib, and the broader immunology pipeline, where any positive progression would reinforce the company’s growth profile.